Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population
- PMID: 24954823
- PMCID: PMC11503659
- DOI: 10.1016/j.jaac.2014.03.005
Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population
Abstract
Objective: The present study aims to compare the prevalence and clinical correlates of DSM-IV versus DSM-5-defined attention-deficit/hyperactivity disorder (ADHD) and subtypes in a nationally representative sample of US youth based on the age-of-onset criterion.
Method: The sample includes 1,894 participants 12 to 15 years of age from cross-sectional National Health and Nutrition Examination Survey (NHANES) surveys conducted from 2001 to 2004. Data on DSM-IV and DSM-5 criteria for ADHD were derived from administration of the parental ADHD module of the National Institute of Mental Health (NIMH) Diagnostic Interview Schedule for Children, Version IV (DISC-IV).
Results: Extension of the age-of-onset criterion from 7 to 12 years led to an increase in the prevalence rate of ADHD from 7.38% (DSM-IV) to 10.84% (DSM-5). Youth with later age of onset did not differ from those with earlier age of onset in terms of severity and patterns of comorbidity. However, the group with later age of onset was more likely to be from lower income and ethnic minority families.
Conclusion: The comparability of the clinical significance of the early and later age-of-onset groups supports the DSM-5 extension of the age-of-onset criterion in ADHD.
Keywords: ADHD; NHANES; age of onset; epidemiology; prevalence.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure: Drs. Vande Voort and Merikangas and Mss. He and Jameson report no biomedical financial interests or potential conflicts of interest.
Figures
Comment in
-
How evidence on the developmental nature of attention-deficit/hyperactivity disorder can increase the validity and utility of diagnostic criteria.J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):723-5. doi: 10.1016/j.jaac.2014.04.012. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 24954821 No abstract available.
References
-
- Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894–921. - PubMed
-
- Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007 Sep;11(2):106–113. - PubMed
-
- Frick PJ, Lahey BB, Applegate B, et al. DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates. J Am Acad Child Adolesc Psychiatry. 1994 May;33(4):529–539. - PubMed
-
- Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994 Nov;151(11):1673–1685. - PubMed
-
- Lubke GH, Muthen B, Moilanen IK, et al. Subtypes versus severity differences in attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort. J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1584–1593. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
